Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing

European Journal of Cancer. Part B: Oral Oncology

Volumn 29, Issue 2, 1993, Pages 147-150

  Ranasinghe, A W ^a   Warnakulasuriya, K A A S ^a   Johnson, N W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETEL EXTRACT; ONCOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOUTH CARCINOMA; TOBACCO;

ADULT; AGED; AGED, 80 AND OVER; ARECA; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMAN; MALE; MIDDLE AGE; MOUTH NEOPLASMS; MUTATION; NEOPLASM STAGING; PLANTS, MEDICINAL; PLANTS, TOXIC; PREVALENCE; PROTEIN P53; SRI LANKA; SUPPORT, NON-U.S. GOV'T; TOBACCO, SMOKELESS;

EID: 0027285474     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(93)90038-G     Document Type: Article

References (41)

1. A global view of the epidemiology of oral cancer
2. Cancer in Sri Lanka with especial reference to oral cancer
3. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers
4. An epidemiological study of oral and oropharyngeal cancer in Central and South East Asia
5. IARC monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans
6. Oral cancer
7. Oncogenes and onco-suppressor genes: Their involvement in cancer
8. Oncogenes and anti-oncogenes; The molecular basis of tumour behaviour
9. The p53 tumour suppressor gene and product
10. N-nitroso compounds and tobacco-induced cancers in man
11. 3-(Methylnitrosamino) propionitrile: occurrence in saliva of betel quid chewers, carcinogenicity, and DNA methylation in F344 rats
12. Selective targeting of p53 gene mutational hotspots in human cancers by aetiologically defined carcinogens
13. p53 mutations in human cancers
14. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
15. Widespread p53 overexpression in human malignant tumours
16. The p53 proto-oncogene can act as a suppressor of transformation
17. Different tumour-derived p53 mutants exhibit distinct biological activities
18. Cloning and characterization of a cDNA from Xenopus laevis coding a protein homologous to human and murine p53
19. An embryo protein induced by SV 40 virus transformation of mouse cells
20. Post-translational regulation of the 54K cellular tumour antigen in normal and transformed cells
21. Assessment of p53 protein expression in normal, benign and malignant oral mucosa
22. Expression of p53 mutant nuclear phosphoprotein in oral carcinomas and potentially malignant oral lesions
23. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas
24. Isolation of human-p53 specific monoclonal antibodies and their use in the studies of human p53 expression
25. Monoclonal antibodies specific for simian virus 40 tumour antigens
26. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
27. Specific interaction between the p53 cellular tumour antigen and major heat shock proteins
28. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumour antigen p53
29. Expression of tumour suppressor gene p53 in oral cancer
30. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
31. Expression of p53 in premalignant and malignant squamous epithelium
32. Overexpression of p53 protein in basal cell carcinomas of human skin
33. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma
34. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer
35. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters
36. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient
37. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
38. p53 in tumour pathology: can we trust immunocytochemistry